Highlights
Profile claimed by owner
About
Using AI to screen Curable Dementia and other Neurological disease
Neurogait is developing AI based clinical screenings for neurodegenerative Disease including curable dementia, Parkinson's
It is currently conducting clinical pilots in Germany and is integrating its solution under a commercial agreement with a large on-line European patient platform. It is also working on its regulatory approvals.
Identity
| Name | Neurogait |
|---|---|
| Slug | neurogait |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4IX1mNwKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ra'anana |
| HQ address | Ranana, Israel |
Web & social
| Website | https://www.neurogait.com/ |
|---|---|
| https://www.linkedin.com/company/37436801 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
SensingArtificial IntelligenceDeep LearningComputer VisionMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsMedical Devices Industry
Business models
B2B2CB2B
Tags
deep-learningneurosciencedigital-healthcaremachine-learningneurologyartificial-intelligencealzheimers-diseasecomputer-visionparkinsonhome-caremedical-technologiesmachine-visiondiagnosticssensorsearly-detectionmedical-devices
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}